Morgan Stanley’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53B | Buy |
|
|||||
|
2025
Q1 | $2.22B | Sell |
|
|||||
|
2024
Q4 | $1.85B | Buy |
|
|||||
|
2024
Q3 | $1.45B | Sell |
|
|||||
|
2024
Q2 | $1.33B | Buy |
|
|||||
|
2024
Q1 | $1.32B | Sell |
|
|||||
|
2023
Q4 | $2.88B | Buy |
|
|||||
|
2023
Q3 | $1.27B | Buy |
|
|||||
|
2023
Q2 | $1.29B | Buy |
|
|||||
|
2023
Q1 | $1.34B | Sell |
|
|||||
|
2022
Q4 | $1.48B | Buy |
|
|||||
|
2022
Q3 | $951M | Sell |
|
|||||
|
2022
Q2 | $1.1B | Buy |
|
|||||
|
2022
Q1 | $803M | Sell |
|
|||||
|
2021
Q4 | $1.13B | Buy |
|
|||||
|
2021
Q3 | $1.08B | Buy |
|
|||||
|
2021
Q2 | $757M | Buy |
|
|||||
|
2021
Q1 | $600M | Buy |
|
|||||
|
2020
Q4 | $415M | Buy |
|
|||||
|
2020
Q3 | $380M | Buy |
|
|||||
|
2020
Q2 | $448M | Sell |
|
|||||
|
2020
Q1 | $484M | Buy |
|
|||||
|
2019
Q4 | $361M | Buy |
|
|||||
|
2019
Q3 | $308M | Sell |
|
|||||
|
2019
Q2 | $357M | Buy |
|
|||||
|
2019
Q1 | $310M | Sell |
|
|||||
|
2018
Q4 | $338M | Sell |
|
|||||
|
2018
Q3 | $448M | Sell |
|
|||||
|
2018
Q2 | $422M | Sell |
|
|||||
|
2018
Q1 | $494M | Sell |
|
|||||
|
2017
Q4 | $713M | Buy |
|
|||||
|
2017
Q3 | $727M | Sell |
|
|||||
|
2017
Q2 | $649M | Buy |
|
|||||
|
2017
Q1 | $584M | Sell |
|
|||||
|
2016
Q4 | $681M | Buy |
|
|||||
|
2016
Q3 | $725M | Sell |
|
|||||
|
2016
Q2 | $786M | Sell |
|
|||||
|
2016
Q1 | $889M | Sell |
|
|||||
|
2015
Q4 | $1.07B | Buy |
|
|||||
|
2015
Q3 | $883M | Buy |
|
|||||
|
2015
Q2 | $825M | Sell |
|
|||||
|
2015
Q1 | $778M | Sell |
|
|||||
|
2014
Q4 | $770M | Buy |
|
|||||
|
2014
Q3 | $808M | Buy |
|
|||||
|
2014
Q2 | $572M | Buy |
|
|||||
|
2014
Q1 | $424M | Buy |
|
|||||
|
2013
Q4 | $446M | Buy |
|
|||||
|
2013
Q3 | $302M | Sell |
|
|||||
|
2013
Q2 | $261M | Buy |
|